Abstract
Hepatic encephalopathy (HE) is normally diagnosed by neuropsychological (NP) tests. The goals of this study were to quantify cerebral metabolites, separate glutamate (Glu) from glutamine (Gln) in patients with minimal hepatic encephalopathy (MHE) as well as healthy subjects using the prior-knowledge fitting (ProFit) algorithm on data acquired by two-dimensional (2D) localized correlated spectroscopy (L-COSY) on two different MR scanners, and to correlate the metabolite changes with neuropsychological (NP) tests. We studied 14 MHE patients and 18 healthy controls using a GE 1.5 T Signa MR scanner. Another group of 16 MHE patients and 18 healthy controls were studied using a Siemens 1.5 T Avanto MR scanner. The following parameters were used for L-COSY: TR/TE = 2 s/30 ms, 3 × 3 × 3 cm3 voxel size, 96 Δt1 increments with 8 averages per Δt1. Using the ProFit algorithm, we were able to differentiate Gln from Glu on the GE 1.5 T data in the medial frontal white/gray matter. The ratios of myo-inositol (mI), Glu, total choline, scyllo-inositol (sI), phosphoethanolamine (PE), and total N-acetyl aspartate (NAA) showed statistically significant decline in HE patients compared to healthy controls, while the ratio of Gln was significantly increased. Similar trend was seen in the ProFit quantified Siemens 1.5 T data in the frontal and occipito-parietal white/gray regions. Among the NP domain scores, motor function, cognitive speed, executive function and the global scores showed significant differences. Excellent correlations between various NP domains and metabolite ratios were also observed. ProFit based cerebral metabolite quantitation enhances the understanding and basis of the current hypothesis of MHE.
Similar content being viewed by others
References
Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A (1999) Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29:1662–1667
Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A (2001) Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 35:37–45
Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19:253–267
Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving detection of minimal hepatic encephalopathy using the inhibitory control task. Gastroenterology 139:510–518
Berl S, Tokagaki G, Clarke DD, Waelsch H (1962) Metabolic compartments in vivo. Ammonia and glutamic acid metabolism in brain and liver. J Biol Chem 237:2562–2569
Bernthal P, Hayes A, Tarter RE, Van Thiel D, Lecky J, Hegedus A (1987) Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 7:107–114
Bhujwalla ZM, Aboagye EO, Gillies RJ, Chacko VP, Mendola CE, Backer JM (1999) Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro. Magn Reson Med 41:897–903
Binesh N, Huda A, Bugbee M, Gupta R, Rasgon N, Kumar A, Green M, Han S, Thomas MA (2005) Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaging 21:398–405
Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F (2006) Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 7:86–96
Blei AT, Cordoba J (1996) Subclinical encephalopathy. Digest Dis 14:2–11
Bosman DK, Deutz NE, De Graaf AA, vd Hulst RW, Van Eijk HM, Bovée WM, Maas MA, Jörning GG, Chamuleau RA (1990) Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative 1H-NMR spectroscopy and biochemical investigation. Hepatology 12:281–290
Butterworth RF (1995) Hepatic encephalopathy. Neurologist 1:95–104
Butterworth RF (1996) Taurine in hepatic encephalopathy. Adv Exp Med Biol 403:601–606
Butterworth RF (2000) Complication of cirrhosis. III. Hepatic encephalopathy. J Hepatol 32:171–180
Chalasani N, Gitlin N (1997) Subclinical hepatic encephalopathy: How best to diagnose? Am J Gastroent 92:905–906
Chih CP, Roberts EL Jr (2003) Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J Cereb Blood Flow Metab 23:1263–1281
Clarke DD, Sokoloff L (1999) Circulation and energy metabolism of the brain. In: Siegel GJ, Agranoff BW et al (eds) Basic neurochemistry. Lippincott-Raven, Philadelphia, pp 637–669
Dhiman RK, Chawla YK (2009) Minimal hepatic encephalopathy. Indian J Gastroenterol 28:5–16
Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CTW (1993) Multisection proton MR spectrosocopic imaging of the brain. Radiology 188:277–282
Evanochko WT, Sakal TT, Ng TC, Krishnaa NR, Kimc HD, Zeidlerc RB, Ghantad VK, Brockmane RW, Schifferf LM, Braunschweigerf PG, Glicksona JD (1984) NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. Biochim Biophys Acta 805:104–116
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721
Foerster BR, Conklin LS, Petrou M, Barker PB, Schwarz KB (2009) Minimal hepatic encephalopathy in children: evaluation with proton MR spectroscopy. AJNR Am J Neuroradiol 30:1610–1613
Fraser CL, Arieff AI (1985) Hepatic encephalopathy. New Eng J Med 313:865–873
Frias-Martinez E, Rajakumar N, Liu X, Singhal A, Banakar S, Lipnick S, Verma G, Ramadan S, Kumar A, Thomas MA (2008) ProFit-based Quantitation of Cerebral Metabolites using 2D L-COSY at 3 T Magnetic Resonance. Proc Intl Soc Mag Reson Med 16: 691, Toronto, Canada
Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO Jr, McClain CJ (1980) Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 140:519–521
Gitlin N (1996) Hepatic encephalopathy. In: Zorkin D, Boyer TD (eds) Hepatology. Saunders, Philadelphia, pp 605–617
Govindaraju V, Young K, Maudsley AA (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13:129–153
Griffiths JR, Cady E, Edwards RHT, McCready VR, Wilkie DR, Wiltshaw E (1983) 31P-NMR studies of a human tumour in situ. Lancet 1:1435–1436
Gruetter R, Novotny EJ, Boulware SD, Mason GF, Rothman DL, Shulman GI, Prichard JW, Shulman RG (1994) Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J Neurochem 63:1377–1385
Haase A, Frahm J, Haenicke W, Matthaei D (1985) 1H NMR chemical-shift selective (CHESS) imaging. Phys Med Biol 30:341–344
Heaton RK, Grant I, Matthews CG (1991) Comprehensive norms for an expanded Halstead-Reitan battery: demographic corrections, research findings, and clinical applications. Psychological Assessment Resources, Odessa
Hilbe JM (2009) Logistic regression models. Chapman & Hall/CRC Press
Hilgier W, Law RO, Zielinska M (2000) Taurine, glutamine, glutamate, and aspartate content and efflux, cell volume of cerebrocortical minislices of rats with hepatic encephalopathy. Adv Exp Med Biol 483:305–312
Hosmer DW, Lemeshow S (1995) Applied Logistic Regression. John Wiley and Sons, Inc Menard, Scott
Kaibara T, Tyson RL, Sutherland GR (1998) Human cerebral neoplasms studied using MR spectroscopy: a review. Biochem Cell Biol 76:477–486
Klein J, Gonzalez R, Koppen A, Loffelholz K (1993) Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 22:293–300
Koc H, Mar M, Ranasinghe A, Swenberg JA, Zeisel SH (2002) Quantitation of Choline and its Metabolites in Tissues and Foods by Liquid Chromatography/Electrospray Ionization-Isotope Dilution Mass Spectrometry. Analytical Chemistry 74:4734–4740
Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19–27
Larzelere RE, Mulak SA (1977) Single-sample tests for many correlations. Psychol Bull 84:557–569
Lavoie J, Giguere JF, Layrargues GP, Butterworth RF (1987) Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. J Neurochem 49:692–697
Leybaert L (2005) Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? J Cereb Blood Flow Metab 25:2–16
Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York, pp 333–685
Lockwood AH (2000) “What’s in a name?” Improving the care of cirrhotics. J Hepatol 32:859–861
Lockwood AH, Yap EWH, Wong WH (1991a) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cerebral Blood Flow Metabol 11:337–341
Lockwood AH, Yap EWH, Rhodes HM, Wong WH (1991b) Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cerebral Blood Flow Metabol 11:331–336
Loening NM, Chamberlin AM, Zepeda AG, Gonzalez RG, Cheng LL (2005) Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy. NMR in Biomedicine 18:413–420
Magistretti PJ, Pellerin L, Rothman DL, Shulman RG (1999) Energy on demand. Science 283:496–497
McCrea M, Cordoba I, Vessey G, Blei AT, Randolph C (1996) Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 53:758–763
McPhail MJ, Taylor-Robinson SD (2010) The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Metab Brain Dis 25:65–72
Miller BL, Chang L, Booth R, Ernst T, Cornford M, Nikas D, McBride D, Jenden DJ (1996) In Vivo 1H MRS Choline: Correlation with In Vitro Chemistry/Histology. Life Sciences 58:1929–1935
Mullen KD (2007) Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 25:11–16
Ogg RJ, Kingsley PB, Taylor JS (1994) WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 104:1–10
Patel N, Forton DM, Coutts GA, Thomas HC, Taylor-Robinson SD (2000) Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study. Metab Brain Dis 15:223–240
Pardridge WM, Cornford EM, Braun LD, Oldendorf WH (1979) Transport of choline and choline analogues through the blood-brain barrier. In: Barbeau A, Growdon JH, Wurtman RJ (eds) Nutrition and the Brain. Raven, New York, pp 25–33
Pellerin L, Magistretti PJ (1997) Glutamate uptake stimulates Na+, K+-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabian. J Neurochem 69:2132–2137
Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679
Romero-Gómez M (2007) Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy. J Hepatol 47:10–11
Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, de Madaria E, Montoliu C, Nuñez D, Flavia M, Compañy L, Rodrigo JM, Felipo V (2007) Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45:879–885
Ross BD, Danielsen ER, Bluml S (1996) Proton magnetic resonance spectroscopy: The new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Digest Dis 14:30–39
Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA (1994) Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 193:457–463
Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK (2002) Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 22:190–197
Schomerus H, Hamster W (1998) Neuropsychological aspects of portalsystemic encephalopathy. Metab Brain Dis 13:361–377
Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W (1981) Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 26:622–630
Schulte RF, Boesiger P (2006) ProFit: two-dimensional prior-knowledge fitting of J-resolved spectra. NMR Biomed 19:255–263
Singhal A, Nagarajan R, Hinkin CH, Kumar R, Sayre J, Elderkin-Thompson V, Huda A, Gupta RK, Han SH, Thomas MA (2010) Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo. J Magn Reson Imaging 32:35–43
Smith SA, Levante TO, Meier BH, Ernst RR (1994) Computer-simulations in magnetic-resonance-an object-oriented programming approach. J Magn Reson A 106:75–105
Solivera J, Cerdan S, Pascual JM, Barrios L, Roda JM (2009) Assessment of 31P-NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors. NMR in Biomedicine 22:663–674
Stewart CA, Smith GE (2007) Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 4:677–685
Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE (1984) Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 86:1421–1427
Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, Bell JD, Bryant DJ, Coutts GA, Morgan MY (1994) Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 20:1173–1178
Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD (1999) Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 19:389–398
Thomas MA, Yue K, Binesh N, Davanzo P, Kumar A, Siegel B, Frye M, Curran J, Lufkin R, Martin P, Guze B (2001) Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med 46:58–67
Vaquero J, Butterworth RF (2006) The brain glutamate system in liver failure. J Neurochem 98:661–669
Wang YM (2004) The definition, nomenclature and diagnosis of hepatic encephalopathy. Zhonghua Gan Zang Bing Za Zhi 12:305–306
Weissenborn K, Ahl B, Fischer-Wasels D, van den Hoff J, Hecker H, Burchert W, Köstler H (2007) Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut 56:1736–1742
Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773
Zimmerman C, Winnefeld K, Streck S, Roskosb M, Haberla RL (2004) Antioxidant status in acute stroke patients and patients at stroke risk. Eur Neurol 51:157–161
Zwingmann C, Chaturet N, Leibiritz D, Butterworth RF (2003) Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology 37:420–428
Acknowledgements
This research was supported by a National Institute of Mental Health (NIMH) RO1 grant (1R01MH06569501A1). Scientific support of Drs. Nader Binesh, Kenneth Yue, Shida Banakar, and Sherry Liu during the earlier phase of this project is gratefully acknowledged. Authors acknowledge the support of Dr. Rolf Schulte, Prof. Dr. Peter Boesiger and his group members at ETH-Zurich, Switzerland in sharing the earlier version of the ProFit algorithm for processing the localized 2D J-resolved spectrum.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sarma, M.K., Huda, A., Nagarajan, R. et al. Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy. Metab Brain Dis 26, 173–184 (2011). https://doi.org/10.1007/s11011-011-9250-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-011-9250-1